Weight loss research questions need for GLP-1 drugs
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?
Apr 17, 2026
0
35
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?
Apr 17, 2026
0
35
Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a preclinical study by Weill Cornell Medicine investigators. In the study, published in Nature Metabolism, ...
Feb 23, 2026
0
33
The common rationale for drinking water at meals is that it physically stretches the stomach, triggering fullness so you don't eat too much. But a new Cornell study found no support for that idea in practice. The paper is ...
Jul 16, 2026
0
31
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out ...
Mar 18, 2026
0
31
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Feb 26, 2026
0
31
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
31
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now taking medications like ...
Feb 17, 2026
0
30
Search the web, and you'll find any number of biohacking techniques for promoting healthy lifespan, from taking cold baths to breathing pressurized oxygen to sleeping under a red light.
May 10, 2026
0
30
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, ...
Mar 5, 2026
0
28
While most parents know to limit candy, the true danger of sugar in a child's diet is often hidden in plain sight. A growing body of research reveals that excessive sugar consumption in childhood is linked to a frightening ...
Feb 20, 2026
0
28